BTAI - BioXcel Therapeutics Inc Stock Price and Quote - FINVIZ.com

BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on …

CouponFollow Extension

16%
OFF

BioXcel Therapeutics, Inc. (BTAI) - Yahoo Finance

6 days from now

9.93. -5.16%. BBIO BridgeBio Pharma, Inc. 24.11. -2.74%. Find the latest BioXcel Therapeutics, Inc. (BTAI) stock quote, history, news and other vital information to help you with your stock ...

yahoo.com

$127
OFF

BTAI Stock Price | BioXcel Therapeutics Inc. Stock Quote (U.S.: …

6 days from now

4 days ago · BioXcel Therapeutics price target cut to $127 from $150 at Truist Securities, stock rated buy. Apr. 1, 2021 at 6:59 a.m. ET by Tonya Garcia.

marketwatch.com

$12.05
OFF

BTAI | BioXcel Therapeutics Inc. Stock Price & News - WSJ

6 days from now

BioXcel Therapeutics Inc. BTAI (U.S.: Nasdaq) BioXcel Therapeutics Inc. View All companies. REAL TIME 10:18 AM EDT 07/19/23. $12.05 USD.

wsj.com

$0.58
OFF

BioXcel Therapeutics Stock Price | BTAI Stock Quote, News, And …

6 days from now

Discover the best brokers for stock trading and ordering other assets! On Wednesday 11/20/2024 the closing price of the BioXcel Therapeutics Inc Registered Shs share was $0.58 on BTT. …

businessinsider.com

89%
OFF

BioXcel Therapeutics Inc (BTAI) Q3 2024 Earnings Call Highlights ...

6 days from now

Nov 15, 2024 · BioXcel Therapeutics Inc (NASDAQ:BTAI) reported an 89% increase in net revenue for the nine months ended September 30, 2024, compared to the same period in …

yahoo.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 ... - Markets Insider

6 days from now

1 day ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial …

businessinsider.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million

6 days from now

1 day ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial …

globenewswire.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

1 day ago · BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript BioXcel announces common stock and warrants offering, no amount given BioXcel Therapeutics …

seekingalpha.com

$1.31
OFF

What To Expect From BioXcel Therapeutics Inc (BTAI) Q3 2024 …

6 days from now

Nov 13, 2024 · BioXcel Therapeutics Inc (NASDAQ:BTAI) is set to release its Q3 2024 earnings on Nov 14, 2024. The consensus estimate for Q3 2024 revenue is $1.31 million, and the …

yahoo.com

$7
OFF

BioXcel Therapeutics Announces $7M Public Offering At $0.48 Per …

6 days from now

1 day ago · BioXcel Therapeutics (BTAI) has announced the pricing of a $7.0 million public offering, consisting of 5,600,000 shares of common stock and warrants to purchase up to …

stocktitan.net

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence …

bioxceltherapeutics.com

FAQs about BTAI - BioXcel Therapeutics Inc Stock Price and Quote - FINVIZ.com Coupon?

Who owns bioxcel Therapeutics (btai)?

It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT. View BioXcel Therapeutics, Inc. BTAI stock quote prices, financial information, real-time forecasts, and company news from CNN. ...

Who owns bioxcel Therapeutics Inc?

It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT. BTAI | Complete BioXcel Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ...

What is the price target for bioxcel Therapeutics Inc registered SHS (BTT)?

Compared to the opening price on Thursday 08/22/2024 on BTT of $0.67, this is a drop of 2.47%. BioXcel Therapeutics Inc Registered Shs's market capitalization is $27.14 M by 40.74 M shares outstanding. *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. Selling, General & Admin. Exp. ...

What is bioxcel Therapeutics Inc registered SS's market capitalization?

BioXcel Therapeutics Inc Registered Shs's market capitalization is $27.14 M by 40.74 M shares outstanding. *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. Selling, General & Admin. Exp. * Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet ...

Did you know bioxcel Therapeutics has a European Patent?

NEW HAVEN - BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a biopharmaceutical firm leveraging artificial intelligence in drug development, announced the granting of a European patent... A lot of people have been following the healthcare market these days, if for no other reason than they now have a deeply personal connection to it thanks to Covid-19. ...

How many warning signs are there with btai?

GuruFocus has detected 6 Warning Signs with BTAI. Over the past 90 days, revenue estimates for BioXcel Therapeutics Inc (NASDAQ:BTAI) for the full year 2024 have declined from $4.72 million to $4.70 million, and for 2025 from $9.55 million to $8.84 million. ...